Related references
Note: Only part of the references are listed.Improvement of IFNγ ELISPOT Performance Following Overnight Resting of Frozen PBMC Samples Confirmed Through Rigorous Statistical Analysis
Radleigh Santos et al.
CELLS (2015)
Harmonisation of short-term in vitro culture for the expansion of antigen-specific CD8+ T cells with detection by ELISPOT and HLA-multimer staining
Lindsey Chudley et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Linking T-cell receptor sequence to functional phenotype at the single-cell level
Arnold Han et al.
NATURE BIOTECHNOLOGY (2014)
Single-cell technologies for monitoring immune systems
Pratip K. Chattopadhyay et al.
NATURE IMMUNOLOGY (2014)
Triple Cytokine FluoroSpot Analysis of Human Antigen-Specific IFN-γ, IL-17A and IL-22 Responses
Tomas Dillenbeck et al.
Cells (2014)
Stepping up ELISpot: Multi-Level Analysis in FluoroSpot Assays
Sylvia Janetzki et al.
Cells (2014)
Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer
Nadeem A. Sheikh et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
A harmonized approach to intracellular cytokine staining gating: Results from an international multiconsortia proficiency panel conducted by the Cancer Immunotherapy Consortium (CIC/CRI)
Lisa K. McNeil et al.
CYTOMETRY PART A (2013)
Optimization of a human IgG B-cell ELISpot assay for the analysis of vaccine-induced B-cell responses
Maja Jahnmatz et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2013)
Enzyme-linked immunospot assays for direct ex vivo measurement of vaccine-induced human humoral immune responses in blood
Giulietta Saletti et al.
NATURE PROTOCOLS (2013)
Overnight Resting of PBMC Changes Functional Signatures of Antigen Specific T-Cell Responses: Impact for Immune Monitoring within Clinical Trials
Sarah Kutscher et al.
PLOS ONE (2013)
Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
Katie J. Ewer et al.
NATURE COMMUNICATIONS (2013)
Harmonization of the intracellular cytokine staining assay
Marij J. P. Welters et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
T Cell Assays and MIATA: The Essential Minimum for Maximum Impact
C. M. Britten et al.
IMMUNITY (2012)
Raise standards for preclinical cancer research
C. Glenn Begley et al.
NATURE (2012)
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
Steffen Walter et al.
NATURE MEDICINE (2012)
Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society
R. Mallone et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
Harmonization of Immune Biomarker Assays for Clinical Studies
Sjoerd H. van der Burg et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Performance of serum-supplemented and serum-free media in IFNγ Elispot Assays for human T cells
Sylvia Janetzki et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Response definition criteria for ELISPOT assays revisited
Z. Moodie et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
The effect of apoptotic cells on virus-specific immune responses detected using IFN-gamma ELISPOT
Kevin Lenders et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2010)
The role of IFN-gamma Elispot assay in HIV vaccine research
Hendrik Streeck et al.
NATURE PROTOCOLS (2009)
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia.
Gemma G. Kenter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Identification of Major Factors Influencing ELISpot-Based Monitoring of Cellular Responses to Antigens from Mycobacterium tuberculosis
Steven G. Smith et al.
PLOS ONE (2009)
The CIMT-monitoring panel:: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays
C. M. Britten et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)
S. Janetzki et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Detection of HIV vaccine-induced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assay
Sheri Dubey et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
Quality assurance for polychromatic flow cytometry
Stephen P. Perfetto et al.
NATURE PROTOCOLS (2006)
Intracellular cytokine optimization and standard operating procedure
Laurie Lamoreaux et al.
NATURE PROTOCOLS (2006)
Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice
T Meier et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Granulocyte contamination dramatically inhibits spot formation in AIDS virus-specific ELISpot assays: Analysis and strategies to ameliorate
R De Rose et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2005)
Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials
JH Cox et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2005)
Evaluation of Elispot assays: influence of method and operator on variability of results
S Janetzki et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
A Fluorospot assay to detect single T lymphocytes simultaneously producing multiple cytokines
A Gazagne et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays
JR Currier et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Use of overlapping peptide mixtures as antigens for cytokine flow cytometry
HT Maecker et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
HPC viability measurement: trypan blue versus acridine orange and propidium iodide
K Mascotti et al.
TRANSFUSION (2000)
Share Paper
